What Selank Does
Selank is a synthetic heptapeptide — a modified analog of tuftsin, a naturally occurring immunomodulatory peptide fragment of IgG. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank is approved in Russia as an anxiolytic and nootropic medication. It reduces anxiety without sedation and enhances cognitive function without stimulation — a combination that pharmaceutical drugs rarely achieve.
The mechanisms that matter:
- GABA system modulation — Selank influences GABAergic tone in the limbic system, particularly the amygdala and hippocampus. Unlike benzodiazepines (which directly agonize GABA-A receptors), Selank modulates the balance of inhibitory signaling without directly binding — producing anxiolysis without sedation, tolerance, or dependence
- Serotonin metabolism — alters the metabolism of serotonin and its metabolites in the brain, contributing to mood stabilization and reduced anxiety. Studies show changes in 5-HT levels in the hypothalamus and frontal cortex
- Dopamine and norepinephrine modulation — influences catecholamine turnover, contributing to improved focus and motivation without the jitteriness of stimulants
- BDNF expression — upregulates brain-derived neurotrophic factor, promoting neuroplasticity, learning, and long-term cognitive function. This is a mechanism shared with exercise and certain antidepressants
- Enkephalin stabilization — inhibits enkephalin-degrading enzymes, prolonging the activity of endogenous opioid peptides involved in stress resilience and emotional regulation
Why Selank Is Different From Anxiolytics
The critical distinction:
| Feature | Selank | Benzodiazepines | SSRIs |
|---|---|---|---|
| Onset | Days (full effect) | Minutes | 4–6 weeks |
| Sedation | None | Significant | Mild-moderate |
| Cognitive impact | Enhances | Impairs | Neutral to mild impairment |
| Addiction potential | None | High | None (but discontinuation syndrome) |
| Tolerance | None | Develops quickly | Partial |
| Withdrawal | None | Severe (potentially dangerous) | Can be significant |
| Sexual side effects | None | Mild | Common (30–70%) |
| Duration of use | Cycled (14–30 days) | Short-term only (2–4 weeks) | Long-term |
When Selank makes sense: Generalized anxiety, stress sensitivity, performance anxiety, cognitive fog associated with anxiety, desire to avoid pharmaceutical side effects. Selank is not appropriate for acute panic attacks (too slow onset) or severe clinical anxiety disorders (insufficient potency as monotherapy).
Dosing Protocol
Standard Protocol
| Parameter | Detail |
|---|---|
| Dose | 250–750 mcg per administration |
| Frequency | 1–3 times daily |
| Route | Intranasal (preferred) or subcutaneous injection |
| Cycle length | 14–30 days on, 14 days off |
| Best timing | Morning, midday, and/or early evening |
Dose Selection
| Dose | Use Case |
|---|---|
| 250 mcg | Starting dose, mild anxiety, assess tolerance |
| 500 mcg | Standard dose — effective for most users |
| 750 mcg | Higher dose for significant anxiety or cognitive demands |
Start at 250 mcg once or twice daily. After 3–5 days, increase to 500 mcg if well-tolerated but effects are insufficient. Most users find 250–500 mcg 2–3x daily to be the sweet spot.
Timing Strategy
- Morning dose — sets an anxiolytic and cognitive baseline for the day
- Midday dose — maintains effect through the afternoon slump
- Early evening dose (optional) — extends into the evening for social situations or wind-down. Avoid dosing within 2 hours of sleep — while Selank isn’t stimulating, the cognitive clarity can delay sleep onset in some users
Intranasal Administration
Selank is most commonly used as a nasal spray. Research-grade Selank comes as lyophilized powder that is reconstituted and loaded into a nasal spray bottle.
Reconstitution for nasal use:
- Reconstitute the vial with bacteriostatic water to your target concentration
- Transfer to a metered nasal spray bottle (typically delivers 100 mcL per spray)
- For a 5 mg vial reconstituted with 2 mL BAC water: concentration = 2,500 mcg/mL. Each 100 mcL spray = 250 mcg.
| Dose | Sprays (at 250 mcg/spray) |
|---|---|
| 250 mcg | 1 spray per nostril (alternate nostrils) |
| 500 mcg | 1 spray per nostril |
| 750 mcg | 1 spray in one nostril + 1 spray in each nostril |
Technique: Tilt head slightly forward, insert nozzle into nostril, spray while gently inhaling. Do not sniff aggressively — this pushes the solution past the absorptive nasal mucosa into the throat.
Subcutaneous Injection
For a 5 mg vial — add 2 mL bacteriostatic water:
| Dose | Volume to Draw |
|---|---|
| 250 mcg | 10 units on insulin syringe |
| 500 mcg | 20 units |
| 750 mcg | 30 units |
Concentration: 2,500 mcg/mL. Inject subcutaneously into the abdomen or thigh.
Storage: Refrigerate at 2–8°C. Reconstituted solution stable for 28 days. Nasal spray bottles should also be refrigerated.
Cycling
Selank is typically cycled, not used continuously:
- Standard cycle: 14–21 days on, 14 days off
- Extended cycle: 30 days on, 14–21 days off
- Rationale: While Selank doesn’t produce tolerance, cycling maintains receptor sensitivity and allows assessment of baseline anxiety levels without the peptide
Some users run Selank continuously for 2–3 months during high-stress periods (exam seasons, work deadlines, life transitions) and then take 3–4 weeks off. There is no evidence of harm from extended use, but cycling is the standard practice.
What the Research Says
Selank has a meaningful clinical evidence base, primarily from Russian research:
Anxiety (GAD equivalent): A randomized controlled trial in patients with generalized anxiety showed Selank (intranasal, 3x daily for 14 days) produced statistically significant reduction in anxiety scores (Hamilton Anxiety Rating Scale) compared to placebo. Effects were comparable to low-dose benzodiazepine therapy but without sedation or cognitive impairment. Published in Zhurnal Nevrologii i Psikhiatrii.
Cognitive function: Studies in healthy volunteers showed improved memory consolidation, attention, and information processing after 14-day Selank courses. Effects were measured using standard neuropsychological batteries and EEG analysis showing increased alpha-wave activity (associated with calm focus).
GABA and monoamine modulation: Animal studies confirmed Selank’s effects on GABA metabolism in the hippocampus and frontal cortex, serotonin turnover in the hypothalamus, and catecholamine balance in reward circuits. The anxiolytic effect maps to limbic GABA modulation; the nootropic effect maps to cortical monoamine optimization.
BDNF upregulation: Selank increases BDNF mRNA expression in the hippocampus — the same neuroplasticity mechanism targeted by exercise, meditation, and certain antidepressants. This may explain why cognitive benefits accumulate over days and persist briefly after discontinuation.
Immunomodulation: As a tuftsin analog, Selank has documented immunomodulatory effects — enhancing IL-6 expression and modulating inflammatory pathways. This immune component is secondary to its nootropic use but may contribute to overall well-being.
Safety
Side Effects
Selank has one of the cleanest side effect profiles of any anxiolytic compound:
| Side Effect | Frequency | Notes |
|---|---|---|
| Nasal irritation | ~10% (intranasal only) | Mild, transient. Related to BAC water preservative |
| Fatigue | ~5% | Usually in the first 1–3 days as anxiety decreases |
| Mild headache | ~3% | Typically resolves by day 2–3 |
No serious adverse events have been reported in clinical trials. No cardiovascular effects. No hepatotoxicity. No hormonal disruption. No sexual side effects.
Important Notes
No drug interactions identified. Selank does not inhibit cytochrome P450 enzymes and has no known interactions with common medications. However, combining with other GABAergic substances (alcohol, benzodiazepines, gabapentin) may produce additive effects — exercise caution.
Not a replacement for severe anxiety treatment. Selank is effective for mild-to-moderate anxiety and cognitive enhancement. Severe generalized anxiety disorder, panic disorder, and PTSD typically require pharmaceutical-grade treatment (SSRIs, therapy). Selank can complement these but should not replace them without clinical guidance.
Approved in Russia, not FDA-approved. Available as a research peptide in the US and most Western countries.
Do Not Use If
- Pregnant or breastfeeding (insufficient safety data)
- Under 18 (not studied in minors)
- Active autoimmune conditions (immunomodulatory effects may be unpredictable)
What Comes Next
- Add cognitive stimulation — Semax Protocol is the standard complement (BDNF + dopamine)
- Run the full combination — Nootropic Stack (Selank + Semax together)
- Explore other protocols matched to your goals in the Directory
- Use the Reconstitution Calculator for exact dosing math
Frequently Asked Questions
What does Selank do? +
Selank is a synthetic peptide analog of tuftsin (an endogenous immunomodulatory peptide). It reduces anxiety without sedation by modulating GABA, serotonin, and dopamine systems in the brain. It also enhances cognitive function — improving memory consolidation, focus, and mental clarity. Unlike benzodiazepines, Selank has no addiction potential, no withdrawal effects, and no cognitive impairment.
How does Selank compare to benzodiazepines? +
Selank reduces anxiety through GABA modulation but without the sedation, cognitive impairment, tolerance, dependence, or withdrawal associated with benzodiazepines. Benzodiazepines are GABA-A agonists that directly enhance inhibitory signaling — powerful but blunt. Selank modulates the balance of GABAergic tone without directly agonizing the receptor, producing anxiolysis without the downsides. The tradeoff is that Selank's effects are subtler and build over days, not minutes.
Is Selank addictive? +
No. Selank has no addiction potential and no withdrawal symptoms after discontinuation. This has been confirmed in multiple Russian clinical studies. It does not produce tolerance — the same dose remains effective throughout a cycle. This is one of its primary advantages over pharmaceutical anxiolytics like benzodiazepines or even gabapentinoids.
Can I use Selank with Semax? +
Yes. Selank + Semax is the standard nootropic peptide combination. Selank provides the anxiolytic and mood-stabilizing base while Semax provides cognitive stimulation and neuroprotection. They work through complementary pathways (Selank = GABA/serotonin modulation, Semax = BDNF/dopamine/norepinephrine). The combination is more effective than either alone for anxiety + cognitive performance.
How long does it take for Selank to work? +
Some users notice mild anxiolytic effects within the first 1–2 doses (minutes with intranasal). Full effects — stable mood, reduced baseline anxiety, improved cognitive clarity — typically develop over 5–7 days of consistent use. Selank's mechanism involves modulating neurotransmitter balance and BDNF expression, which takes time to fully activate.
Should I use nasal or injection Selank? +
Intranasal is the standard route — it's what was used in Russian clinical trials and what most users prefer. Bioavailability is good intranasally because the nasal mucosa provides direct access to the CNS. Subcutaneous injection is an alternative with potentially higher systemic bioavailability but is less studied for Selank specifically. Most protocols use intranasal.
Protocol Summary
| Research Dose | 250–750 mcg per dose |
| Frequency | 1–3 times daily |
| Duration | 14–30 day cycles |
| Administration | Intranasal or subcutaneous injection |